Studies on the Antiprogesteronge and the Anti-glucocorticoid Activity of Mifepristone
Yali Ben
Abstract
Yali Ben
Abstract
Objective:To analyse the binding affinities to progesterone and glucocorticoid re-ceptorsof themifepristone. Methods:With radioligand binding assay, the receptor binding affinityof mifepristone to the rabbit uterus cytosol progesterone receptor and the rat liver glucocorticoid re-ceptor were measured. Results:Compared with progesterone, the relative binding affinity of mi-fepristone is396.67±25.32, and the 50% inhibitory concentration is (6.61±1.20) nmol/L; Comparedwith dexamethasone, the relative binding affinity of mifepristone is 344.41 ± 57.41, and the 50%inhibitory concentration is ( 4.21±1.02) n mol/L. Conclusion:Mifepristone, as a strong agent ofantiprogestin, can block progesterone and glucocorticoid activitiesand the anti-glucocorticoid effectof mifepristone should be noticed enough in the clinical use of this drug.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To analyse the binding affinities to progesterone and glucocorticoid re-ceptorsof themifepristone. Methods:With radioligand binding assay, the receptor binding affinityof mifepristone to the rabbit uterus cytosol progesterone receptor and the rat liver glucocorticoid re-ceptor were measured. Results:Compared with progesterone, the relative binding affinity of mi-fepristone is396.67±25.32, and the 50% inhibitory concentration is (6.61±1.20) nmol/L; Comparedwith dexamethasone, the relative binding affinity of mifepristone is 344.41 ± 57.41, and the 50%inhibitory concentration is ( 4.21±1.02) n mol/L. Conclusion:Mifepristone, as a strong agent ofantiprogestin, can block progesterone and glucocorticoid activitiesand the anti-glucocorticoid effectof mifepristone should be noticed enough in the clinical use of this drug.
Key concepts: Mifepristone, Glucocorticoid, Glucocorticoid receptor, Antiglucocorticoid, Progesterone receptor, Endocrinology, Internal medicine, Chemistry